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Venous thromboembolism (VTE) is a potential complication occurring after total knee arthroplasty 
(TKA).  We investigated the incidence of VTE after TKA using contrast-enhanced computed tomogra-
phy (CT),  and assessed the eﬃcacy of VTE prophylaxis (fondaparinux and enoxaparin).  At our hos-
pital,  189 patients (225 knees) underwent TKA between April 2007 and October 2011.  The 225 knees 
were divided into a control group with no VTE prophylaxis (31 cases),  a fondaparinux group (107 
cases),  and an enoxaparin group (87 cases).  Contrast-enhanced CT screening for VTE was performed 
in all cases on day 5 or 6 after TKA.  D-dimer levels were measured on day 5 after TKA,  and were 
signiﬁcantly lower in the fondaparinux (9.8±3.8) and enoxaparin groups (9.4±4.9) than in the control 
group (15.6±9.8) (p＜0.001).  However,  no statistically signiﬁcant diﬀerence in the incidence of VTE 
was observed among the groups (control,  61.3ｵ; fondaparinux,  49.5ｵ; enoxaparin,  50.6ｵ).  
Prophylaxis was not eﬀective for the prevention of VTE as detected by contrast-enhanced CT after 
TKA.  CT should be performed after TKA,  even when VTE prophylaxis is used.
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enous thromboembolisms (VTEs) are serious 
potential complications after total knee arthro-
plasty (TKA) [1].  The incidence of symptomatic 
VTEs is 0.5-1.0ｵ,  even when heparin or other anti-
coagulants are used [2-4].  Symptomatic pulmonary 
embolisms (PEs) develop in 0.41ｵ; PEs are lethal in 
0.15ｵ of TKA patients.
　 Use of the selective clotting factor Xa inhibitor,  
fondaparinux,  as a VTE prophylactic agent after 
TKA has been permitted in Japan since 2007.  The 
low-molecular-weight heparin,  enoxaparin,  was subse-
quently approved in 2008.  Several published reports 
have evaluated the eﬃcacy of these agents [5-9].  
However,  these studies used venography or lower 
extremity vascular ultrasound for VTE screening;  
detailed assessments of contrast-enhanced CT have not 
been published.
　 The aim of this study was to investigate the inci-
dence of VTE after TKA using contrast-enhanced CT,  
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and to assess the eﬃcacy of VTE prophylaxis.
Materials and Methods
　 All patients provided preoperative written consent 
before the commencement of the study.  The study 
design was approved by the ethics committee of 
Okayama University Graduate School of Medicine,  
Dentistry and Pharmaceutical Sciences under approval 
number 2144.  The subjects of this retrospective 
study were 214 patients (278 knees) who underwent 
TKA at our hospital between April 2007 and 
November 2012.
　 Patients were excluded from the study for any of 
the following reasons: re-replacement,  coagulation 
disorders,  preoperative anticoagulant therapy,  past 
history of VTE,  past history of respiratory distress,  
chest pain,  syncope,  or hypotension,  lower extremity 
swelling or ﬂaring,  impairment of hepatic or renal 
function,  allergy to contrast agents,  preoperative 
D-dimer values above the normal range,  and lack of 
consent for tests.  After screening for the exclusion 
criteria,  189 patients (225 knees) were included in the 
study.
　 The 225 subject knees were divided into the fol-
lowing 4 groups.  Between April 2007 and October 
2008,  the control knees (n＝31) were treated without 
DVT prophylactic agents; only elastic stockings and 
intermittent pneumatic compression devices were used.  
The fondaparinux group (107 knees),  treated between 
July 2007 and October 2009,  received fondaparinux 
(2.5mg/day),  and the enoxaparin group (87 knees),  
treated between November 2009 and October 2011,  
received enoxaparin (2,000-4,000IU/day).  In all cases,  
the use of prophylactic agents began 24-36 hours 
after TKA,  the recommended interval in Japan.
　 Immediately after surgery,  all patients wore elastic 
stockings and used an intermittent pneumatic compres-
sion device.  By the second post-surgical day,  all 
patients began ambulation and gait training.  D-dimer 
levels were measured on day 5 after TKA.  In patients 
undergoing bilateral TKA,  surgery was performed on 
one knee followed by the second procedure,  at least 3 
months later.
　 Contrast-enhanced CT images were obtained from 
the pulmonary apex to the foot in all cases,  and the 
incidences of symptomatic PE,  asymptomatic PE,  and 
DVT were compared.  Contrast-enhanced CT was 
performed 5-6 days after surgery,  using a 64-row 
multi-slice CT (Aquilion 64®; Toshiba Medical 
Systems,  Okayama,  Japan).  The contrast agent,  
Iopamiron® (Bracco,  Milan,  Italy),  was injected into 
an upper-extremity vein (100ml,  4ml/sec).  During the 
arterial phase,  for 22 sec after injection,  imaging was 
performed from the pulmonary apex to the costo-
phrenic angle.  During the venous phase,  300 sec 
after injection of contrast agent,  imaging was per-
formed from the diaphragm to the foot.  All images 
were acquired as 2-mm horizontal axial sections,  from 
which coronal and sagittal sections were recon-
structed.  A radiologist examined the images to deter-
mine the presence of VTEs.
　 When a thrombosis was found in the pulmonary 
artery or its segmental branches,  the patientʼs symp-
toms and physical ﬁndings were conﬁrmed,  and an 
echocardiogram was performed by a cardiovascular 
specialist.  Patients without speciﬁc symptoms,  physi-
cal ﬁndings,  or echocardiographic abnormalities were 
considered to have asymptomatic PEs.  Patients who 
had symptoms such as tachycardia,  hypoxemia,  or 
chest pain or who showed right atrial overload on 
echocardiography,  were considered to have symptom-
atic PEs.  Patients who presented with thrombosis in 
their lower extremities were considered to have DVTs.
　 SPSS version 22.0 for Windows (IBM Japan,  
Ltd.,  Tokyo,  Japan) was used for all statistical analy-
ses.  The normality of continuous variables was con-
ﬁrmed using the Shapiro-Wilk test.  Normally distrib-
uted,  continuous variables were compared using the 
Tukey-Kramer test,  whereas non-normally distributed 
continuous variables were compared using the Steel-
Dwass test.  Fisherʼs exact test was used to compare 
percentages,  and Holmʼs method was used to control 
multiplicity.  The level of statistical signiﬁcance was 
set at p＜0.05.
Results
　 There were no statistically signiﬁcant diﬀerences 
among the groups with regard to age,  gender,  diagno-
sis,  body mass index,  duration of surgery,  duration 
of post-surgical tourniquet use,  or method of anesthe-
sia (Table 1).
　 D-dimer levels on day 5 after TKA were signiﬁ-
cantly lower in the fondaparinux and enoxaparin 
groups than in the control group (p＜0.001).
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　 The incidence of symptomatic PE was lower in the 
enoxaparin group than in the control group,  but the 
diﬀerence was not statistically signiﬁcant (p＝0.067).  
High rates of asymptomatic PE (Fig.  1) and DVT 
were observed in all groups,  but the diﬀerences were 
not statistically signiﬁcant (Table 2).  Patients diag-
nosed with symptomatic PE presented only mild clini-
cal symptoms and physical ﬁndings.  As a result,  PE 
was not suspected based on clinical ﬁndings alone.  The 
diagnosis of symptomatic PE was conﬁrmed by the 
presence of thrombosis in the pulmonary artery using 
contrast-enhanced CT (Fig.  2).
Discussion
　 In the present study,  we used contrast-enhanced 
CT to examine the incidence of VTE after TKA.  Our 
results indicated that VTE prophylaxis was eﬀective 
in lowering D-dimer levels on day 5 after TKA,  but 
did not aﬀect the incidence of VTE as detected by 
contrast-enhanced CT.  CT screening should be per-
formed after TKA,  even when VTE prophylaxis is 
used,  with conversion to anticoagulant therapy if the 
CT is positive for VTE [10].
　 In previous studies,  the incidence of VTE was 
correlated with D-dimer level,  and the incidence after 
TKA was reduced by using prophylactic medication,  
such as fondaparinux and enoxaparin [7-9,  11].  
However,  in these studies,  VTE screening was per-
formed with venography or lower extremity vascular 
ultrasound.  In our study using contrast-enhanced CT,  
with a very high detection level,  the incidence of VTE 
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Table 1　 Patient data
Control (n＝31) Fondaparinux (n＝107) Enoxaparin (n＝87)
Age in years Median [IQR] 73 [64-76] 73 [64-76] 73 [62-76]
Gender, n (%) Male 6 (19.4) 21 (19.6) 16 (18.4)
Female 25 (80.6) 86 (80.4) 71 (81.6)
Diagnosis, n (%)
Osteoarthritis 21 (67.7) 78 (72.9) 56 (64.4)
Rheumatoid arthritis 8 (25.8) 22 (20.6) 27 (31.0)
Osteonecrosis 2 (6.5) 7 (6.5) 4 (4.6)
Bilateral TKA, n (%) 5 (16.1) 17 (15.9) 12 (13.8)
Body mass index (kg/m2) Mean±SD 24.5±3.6 24.4±4.1 25.6±4.3
Duration of surgery (min) Median [IQR] 170 [150-195] 168 [140-195] 175 [155-195]
Duration of tourniquet use (min) Median [IQR] 102 [75-130] 100 [85-130] 90 [90-100]
Method of anesthesia, n (%)
General anesthesia 31 (100.0) 104 (97.2) 87 (100.0)
Spinal anesthesia 0 (0) 3 (2.8) 0 (0)
No statistically signiﬁcant diﬀerence was observed among the groups.
IQR,  inter-quartile range [ﬁrst quartile to third quartile].
Fig. 1　 A 57-year-old woman underwent initial total knee arthroplasty due to right knee osteoarthritis.  Contrast-enhanced computed 
tomography was performed 6 days after surgery.  A,  Thrombosis was detected in the segmental branches of the right pulmonary artery 
(arrow); B,  No thrombosis was evident in the femur or veins of the lower extremity.
in the enoxaparin and fondaparinux groups was not 
signiﬁcantly diﬀerent from that in the control group.
　 VTE screening methods include venography,  lower 
extremity vascular ultrasound,  pulmonary scintigra-
phy,  pulmonary arteriography,  and contrast-enhanced 
computed tomography (CT).  Although venography and 
lower extremity vascular ultrasound can detect deep 
venous thromboses (DVTs) in the lower extremities,  
pulmonary thromboses pose a diagnostic problem.
　 Conversely,  contrast-enhanced CT screening is 
highly sensitive (100ｵ) and speciﬁc (96.6ｵ),  making 
it a useful diagnostic tool [12].  Watanabe et al.  per-
formed contrast-enhanced CT after TKA and found 
asymptomatic PEs in 15.6ｵ of patients and DVTs in 
46.9ｵ [13].  Gandhi et al.  reported post-TKA,  
contrast-enhanced CT-detected asymptomatic PE in 
40.7ｵ [14].
　 The incidence of symptomatic PEs after TKAs,  in 
the absence of prophylaxis,  is approximately 1.0ｵ 
[15,  16].  In the present study,  the incidence of 
symptomatic PEs in the control and fondaparinux 
groups was 6.5ｵ,  higher than that in other reports,  
possibly because contrast-enhanced CT enabled a 
higher detection rate for symptomatic PEs.  Parvizi et 
al.  reported an incidence of 0.21ｵ for symptomatic 
PEs,  diagnosed by lung perfusion scintigraphy.  However,  
when contrast-enhanced CT was used,  the incidence 
increased to 1.72ｵ [4].  The use of contrast-enhanced 
CT in our study may have had a similar eﬀect on the 
incidence of PEs because of the inclusion of asymp-
tomatic PEs,  which are normally diﬃcult to diagnose.  
PE symptoms include transient tachycardia,  hypox-
emia,  and chest pain [17].  However,  the incidence of 
hypoxemia after TKA ranges from 4ｵ to 42ｵ when 
causes other than PE are included.  In addition,  respi-
ratory distress is uncommon in isolated subsegmental 
PE [18].  Therefore,  determination of whether 
hypoxemia and other symptoms that occur after TKA 
are due to PE is diﬃcult,  complicating the diﬀeren-
tial diagnosis of symptomatic PE [19,  20].
　 The reported incidence of asymptomatic PE after 
TKA ranges between 0ｵ and 57ｵ [13,  14,  21,  
22].  Kim et al.  found no cases of PE among 227 TKA 
patients using lung perfusion scintigraphy [21].  
However,  Gandhi et al.  screened 27 patients after 
TKA using contrast-enhanced CT,  and found asymp-
tomatic PE in 41ｵ of them [14].  These results show 
that the incidence of asymptomatic PE varies greatly,  
according to the screening method.  In the present 
study,  the incidence of asymptomatic PE was 19.4ｵ.  
Although this ﬁgure is higher than that reported fol-
lowing lung perfusion scintigraphy,  it is lower than 
that for other contrast-enhanced CT protocols.  This 
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Table 2　 Incidence of deep vein thromboses (DVTs) and pulmonary embolisms (PEs)
Control (n＝31) Fondaparinux (n＝107) Enoxaparin (n＝87)
D-dimer on day 5 after
TKA (ug/ml), mean±SD 15.6±9.8 9.8±3.8
＊ 9.4±4.9＊
VTE, n (%) 19 (61.3) 53 (49.5) 44 (50.6)
Symptomatic PE, n (%) 2 (6.5) 3 (2.8) 0 (0)
Asymptomatic PE, n (%) 6 (19.4) 25 (23.4) 16 (18.4)
DVT, n (%) 11 (35.5) 25 (23.4) 28 (32.2)
＊p＜0.001 vs.  control group.
Fig. 2　 A 77-year-old woman underwent initial total knee arthro-
plasty due to right knee osteoarthritis.  Contrast-enhanced computed 
tomography was performed 6 days after surgery.  Thrombosis was 
detected in the segmental branches of the right pulmonary artery 
(arrow).  Mild hypoxemia was observed on the ﬁrst day after surgery,  
and follow-up observation was conducted during oxygen administra-
tion.  Right atrial overload was noted on an echocardiogram obtained 
by a cardiovascular specialist,  consistent with a diagnosis of 
symptomatic PE.
may have been due to our use of 2-mm slices for imag-
ing,  as well as our initiation of DVT prophylaxis at an 
early stage after surgery.
　 The absence of VTE screening before surgery is a 
possible limitation of the present study.  However,  
because D-dimers before surgery were within the 
normal range in all patients,  the possibility that a 
patient had a pre-surgical VTE was extremely low 
[13].  We speculate that the majority of cases of 
asymptomatic PEs detected in the present study 
developed after surgery.
　 In conclusion,  we performed contrast-enhanced CT 
screening for VTE after TKA,  and assessed the eﬃ-
cacy of contrast-enhanced CT and the VTE prophylac-
tic agents fondaparinux and enoxaparin.  Neither agent 
had a prophylactic eﬀect on VTE detected on con-
trast-enhanced CT.  CT screening should be per-
formed after TKA,  even when VTE prophylaxis is 
used; if the CT is positive for VTE,  medication 
should be converted to anticoagulant therapy.
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